John B. McIntyre - Concepedia

Concepedia

Author

John B. McIntyre

University of Calgary ORCID

Also Known As

J. B. McIntyre, J. Bradley McIntyre, J. McIntyre, J. Mcintyre, J.B. McIntyre, JOHN B. MCINTYRE, John B McIntyre, John B. McIntyre, John B. Mcintyre, John Bradley McIntyre

55

Publications

1.9K

Citations

22

H-Index

65

Concepts

All Affiliations

University of Calgary Alberta Health Services University of Alberta Calgary Laboratory Services Alberta Cancer Foundation

JB

About

John B. McIntyre is an author at University of Calgary specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	1.4K
2	Health Sciences	2	2	47
3	Engineering	1	1	200
4	Natural Sciences	1	1	291
5	Applied Physiology	1	1	24

John B. McIntyre

×

29

Publications

1.9K

Citations

22

H-Index

	Year	Citations
Establishment of Sister Chromatid Cohesion at the S. cerevisiae Replication Fork Armelle Lengronne, John B. McIntyre, Yuki Katou, Molecular Cell ChromatinSister Chromatid CohesionCell DivisionChromatin RemodelingNatural Sciences	2006	291
An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging Sylvia Drabycz, Glòria Roldán, Paula de Robles, NeuroImage Neuro-oncologyRadiation OncologyEngineeringMedical ImagingGlioma	2009	200
POLE exonuclease domain mutation predicts long progression-free survival in grade 3 endometrioid carcinoma of the endometrium Bo Meng, Lien Hoang, John B. McIntyre, Gynecologic Oncology Endometrioid CarcinomaMedicineGynecologyPathologyLong Progression-free Survival	2014	190
A somatic activating NRAS variant associated with kaposiform lymphangiomatosis Sarah Barclay, Kyle Inman, Valerie L. Luks, Genetics in Medicine Autoimmune DiseaseImmunodeficienciesKaposiform LymphangiomatosisImmunologyPathology	2018	132
Toxicity from chemoradiotherapy in older patients with glioblastoma multiforme Angelique Sijben, John B. McIntyre, Glòria Roldán, Journal of Neuro-Oncology Neuro-oncologyOlder PatientsGliomaMedicineHigh-grade Gliomas	2008	130
PIK3CA mutational status and overall survival in patients with cervical cancer treated with radical chemoradiotherapy John B. McIntyre, Jackson Wu, Peter Craighead, Gynecologic Oncology Cervical CancerRadical ChemoradiotherapyMedicinePathologyCancer Treatment	2012	116
Targeted mutation analysis of endometrial clear cell carcinoma Lien Hoang, Melissa K. McConechy, Bo Meng, Histopathology	2014	93
Morphologic Reproducibility, Genotyping, and Immunohistochemical Profiling Do Not Support a Category of Seromucinous Carcinoma of the Ovary Peter Rambau, John B. McIntyre, Jennifer L. Taylor, The American Journal of Surgical Pathology Tumor BiologySeromucinous CarcinomaImmunohistochemical Profiling DoTumoral PathologyCancer Pathology	2017	89
Population-Based Study of Pseudoprogression after Chemoradiotherapy in GBM Glòria Roldán, James N. Scott, John B. McIntyre, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques	2009	64
The diagnostic utility of TP53 and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumors Alon D. Altman, Gregg Nelson, Prafull Ghatage, Modern Pathology Tumoral PathologyDiagnostic UtilityMedicinePathologyGynecology	2013	62

Page 1